Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds

1. A method for treating a tumor comprising administering an effective dose of a compound of formula (I)

to a subject in need thereof,

wherein:

each R 1 , independently, is hydrogen, halogen, or —O—R 4 ;

R 2 is —(CR a R b ) z —R 5 ;

each R 3 , independently, is hydrogen, halogen, —N(R 4 ) 2 , —O—R 4 , alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

each R a , independently, is hydrogen, halogen, hydroxy, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

each R b , independently, is hydrogen, halogen, hydroxy, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

each R 4 , independently, is hydrogen or C 1 -C 6 alkyl;

R 5 is hydrogen, halo, alkyl, hydroxy, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, —N(R 4 )CO—R 4 or Ar;

Ar is aryl or heteroaryl, wherein each of aryl and heteroaryl is optionally substituted by one to five substituents independently selected from hydrogen, halogen, —R 4 , —N(R 4 ) 2 , nitro, —(CH 2 ) n —NHCO—R 4 , —O—R 4 , alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

n is 0, 1, 2, or 3;

x is 0, 1, 2, 3, or 4;

y is 0, 1, 2, 3, or 4; and

z is 0, 1, 2, 3, 4, 5, or 6;

or a pharmaceutically acceptable salt thereof; wherein the tumor is glioblastoma or breast cancer.

2. The method of claim 1 , wherein the tumor is glioblastoma.

3. The method of claim 1 , wherein the tumor is a breast cancer.

4. A method for treating a tumor comprising administering an effective dose of a compound of formula (II):

wherein:

each of R 1a and R 1b , independently, is H, halogen, hydroxy, alkyl, haloalkyl, or alkoxy;

R 2 is acetamidoethyl or Ar, wherein Ar is selected from phenyl and heteroaryl, wherein each of phenyl and heteroaryl is optionally substituted by one to five substituents independently selected from hydrogen, halogen, —R 4 , —N(R 4 ) 2 , nitro, —O—R 4 , —NHCO—CH 3 , —CH 2 —NHCO—CH 3 , and trifluoromethyl;

each of R 3a , R 3b , and R 3c , independently, is H, halogen, hydroxy, alkyl, alkoxy, or —N(R 4 ) 2 ; and

each R 4 , independently, is hydrogen or C 1 -C 6 alkyl; wherein the tumor is glioblastoma or breast cancer.

5. The method of claim 4 , wherein, in the compound of formula (II):

each of R 1a and R 1b , independently, is hydrogen, halogen, or alkoxy;

R 2 is acetamidoethyl, 4-pyrimidinyl, 4-thiazolyl, 3-pyridinyl, or phenyl optionally substituted by 1 to 3 substituents independently selected from hydrogen, halogen, nitro, trifluoromethyl, amino, dimethylamino, —NHCO—CH 3 , —CH 2 —NHCO—CH 3 , methyl, or methoxy;

each of R 3a , R 3b , and R 3c , independently, is hydrogen, halogen, hydroxyl, dimethylamino, methyl or methoxy; and

y is 1 or 2.

6. The method of claim 4 , wherein, in the compound of formula (II):

each R 1 is independently hydrogen or halogen;

R 2 is phenyl, 4-nitrophenyl, 4-aminophenyl, 3-fluorophenyl, 4-fluorophenyl, 2,4-difluorophenyl, 4-methylphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 4-chlorophenyl, 4-(dimethylamino)phenyl, 3-(trifluoromethyl)phenyl, 4-(trifluoromethyl)phenyl, 4-acetamidophenyl, 4-pyrimidinyl, 4-thiazolyl or 3-pyridinyl;

R 3a is hydroxy or methoxy;

R 3b is methoxy, methyl, or dimethylamino; and

R 3c is hydrogen.

7. The method of claim 1 , wherein the compound is selected from the group consisting of:

2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-fluoro-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methylphenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methylphenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-phenylquinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-phenylquinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-phenylquinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-phenylquinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-phenylquinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methoxylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methoxylphenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methoxylphenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydro isoquinoline; 2-[[2-(4-methoxylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-methoxylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-chlorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-chlorophenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-chlorophenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-chlorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-chlorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(dimethylamino)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(dimethylamino)phenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(dimethylamino)phenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(dimethylamino)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(dimethylamino)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-fluorophenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-fluorophenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-fluorophenyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-methoxylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-methoxylphenyl)quinazolin-4-yl]carbonyl]-5, 6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-methoxylphenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-methoxylphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-methoxylphenyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-(trifluoromethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2,4-difluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2,4-difluorophenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2,4-difluorophenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2,4-difluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2,4-difluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-acetamidophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-acetamidophenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-acetamidophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(acetamidomethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(acetamidomethyl)phenyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(acetamidomethyl)phenyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(acetamidomethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-(acetamidomethyl)phenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-pyrimidinyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-pyrimidinyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-pyrimidinyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-pyrimidinyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2-(acetamido)ethyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2-(acetamido)ethyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2-(acetamido)ethyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2-(acetamido)ethyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(2-(acetamido)ethyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-thiazolyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-thiazolyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-thiazolyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-thiazolyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-thiazolyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-pyridinyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-pyridinyl)quinazolin-4-yl]carbonyl]-5,6-dihydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-pyridinyl)quinazolin-4-yl]carbonyl]-5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-pyridinyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-dimethylamino-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3-pyridinyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methyl-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-nitrophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[2-(4-aminophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline; 2-[[6-fluoro-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6-fluoro-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-6methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(4-fluorophenyl)quinazolin-4-yl]carbonyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 2-[[6,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-5,-hydroxy-1,2,3,4-tetrahydroisoquinoline; and 2-[[6,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)quinazolin-4-yl]carbonyl]-6-fluoro-1,2,3,4-tetrahydroisoquinoline; or a pharmaceutically acceptable salt thereof.

8. The method of claim 1 , wherein R 2 is —(CR a R b ) z —N(R 4 )CO—R 4 , or Ar.

9. The method of claim 1 , wherein x is 1 or 2 and each R 1 , independently, is hydrogen, halogen or —OR 4 .

10. The method of claim 1 , wherein y is 1 or 2 and each R 3 , independently, is hydrogen, halogen, —R 4 , —N(R 4 ) 2 , or —OR 4 .

11. The method of claim 1 , wherein the suitable dosage is from 6 to about 90 mg/kg of body weight of the subject.

12. The method of claim 1 , wherein the suitable dosage is from 15 to about 60 mg/kg of body weight of the subject.

13. The method of claim 1 , wherein the compound has a peak plasma concentration of from about 0.5 to about 75 μM.

14. The method of claim 1 , wherein the compound has a peak plasma concentration of from about 2 to about 30 μM.

15. The method of claim 1 , wherein the compound is conjugated to a targeting moiety.

16. The method of claim 15 , wherein the targeting moiety is a polypeptide.

17. The method of claim 1 , wherein the targeting moiety is a ligand that binds to cell antigens or cell surface ligands.

18. The method of claim 17 , wherein the ligand binds to B cell antigen, CD19 antigen, or B43 antigen.

19. A method of inhibiting proliferation of tumor cell in a subject comprising administering an effective dose of a compound of formula (I)

wherein:

each R 1 , independently, is hydrogen, halogen, or —O—R 4 ;

R 2 is —(CR a R b ) z —R 5 ;

each R 3 , independently, is hydrogen, halogen, —N(R 4 ) 2 , —O—R 4 , alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

each R a , independently, is hydrogen, halogen, hydroxy, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

each R b , independently, is hydrogen, halogen, hydroxy, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

each R 4 , independently, is hydrogen or C 1 -C 6 alkyl;

R 5 is hydrogen, halo, alkyl, hydroxy, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, —N(R 4 )CO—R 4 or Ar;

Ar is aryl or heteroaryl, wherein each of aryl and heteroaryl is optionally substituted by one to five substituents independently selected from hydrogen, halogen, —R 4 , —N(R 4 ) 2 , nitro, —(CH 2 ) n —NHCO—R 4 , —O—R 4 , alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

n is 0, 1, 2, or 3;

x is 0, 1, 2, 3, or 4;

y is 0, 1, 2, 3, or 4; and

z is 0, 1, 2, 3, 4, 5, or 6;

or a pharmaceutically acceptable salt thereof.

20. The method of claim 19 , wherein the tumor cell is selected from a group consisting of breast tumors, prostate tumors, colon tumors, ovary tumors, kidney tumors, pancreas tumors, stomach tumors, lung tumors, liver tumors, cervix tumors, glioblastoma, and melanoma.

21. The method of claim 19 , wherein the subject is a human.